Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Drug Discovery & Development’s top stories of 2022

By Brian Buntz | January 4, 2023

Tablets in Drug Discovery & Development feature

Photo by Castorly Stock via Pexels

After the majority of pharmaceutical companies released their earnings reports for 2022, we released our annual Pharma 50 feature detailing how the pharma landscape has evolved. Four of the five most popular pieces of content on Drug Discovery & Development were part of the Pharma 50 feature.

In the past year, Pfizer (NYSE:PFE) cemented its position as the biggest pharma company, thanks in large part to strong sales of its COVID-19 products in 2021, but its stock price lost about 10% of its value over the course of 2022. Meanwhile, the Dow Jones U.S. Pharmaceuticals Index was down close to 6% while the S&P Pharmaceuticals Select Industry Index fell almost 13% in 2022.

1. 50 of 2021’s best-selling pharmaceuticals

The COVID-19 vaccine from Pfizer and BioNTech was far and away the most popular product of 2021.

2. The 50 largest pharmaceutical companies in the world

Strong demand for COVID-19 therapies resulted in a dramatically different pharmaceutical industry landscape and a dramatically different Pharma 50 list of the largest pharmaceutical companies from the year before.

3. The most common monkeypox vaccine side effects

Although generally well-tolerated, the Jynneos vaccine can have significant adverse events in a limited number of individuals.

4. 15 of the best pharma companies to work for

Sage Therapeutics was once again the top-ranked pharmaceutical employer.

5. 50 leading cell and gene therapy companies

Our new ranking of cell and gene therapy companies on Drug Discovery & Development is among the most popular on our site.

 

Most popular Drug Discovery & Development content on social media in 2022

The following articles gained the most traction on LinkedIn.

1. Lilly completes acquisition of Akouos

Late in the year, Eli Lilly and Company announced that it successfully completed its acquisition of Akouos, expanding its efforts in genetic medicines.

2. Kyowa Kirin is targeting disparities in African Americans with rare blood cancer

An executive at Kyowa Kirin North America (KKNA) opened up about the company’s  efforts to address the racial disparities affecting the care and outcomes of African American patients with Cutaneous T-cell Lymphoma (CTCL).

3. Pharma50Talks: How Seer aims to remove technological barriers to studying the proteome

Drug Discovery & Development interviewed the CEO of the proteomics company Seer (Nasdaq:SEER), which has a growing roster of customers, including pharma and biotech companies.

4. LSD-assisted therapy resulted in durable anxiety improvement in Phase 2 study

The psychedelic therapy company MindMed announced upbeat results from a Phase 2 study focused on patients with anxiety.

5. MindMed launches Phase 2b to study LSD in generalized anxiety disorder

Another article on MindMed documents the dosing of the first patient in a Phase 2b dose-optimization trial of MM-120, a pharmaceutically optimized form of lysergic acid diethylamide (LSD).


Filed Under: Cell & gene therapy, Drug Discovery and Development, Oncology
Tagged With: drug discovery
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Collage of close-up male and female eyes isolated on colored neon backgorund. Multicolored stripes. Concept of equality, unification of all nations, ages and interests. Diversity and human rights
How a ‘rising tide’ of inclusivity is transforming clinical trials
Mary Marcus appointed CEO of NewAge Industries
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
Data analytics tools help doctors analyze trends in patient outcomes and population health.
External comparator studies: What researchers need to know to minimize bias
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE